$1.59
-0.27-14.25%
Last update: Nov 10, 1:47 PM
Black Diamond Therapeutics Inc
BDTXNASDAQ
The average analyst price target for Black Diamond Therapeutic is $11.90, 646.1% above the current price. Of 8 analysts, 7 rate it Buy and 1 Hold. Targets range from $6 to $20. The latest change came on Apr 29, 2026, when HC Wainwright & Co. raised its price target on Black Diamond Therapeutic from $10 to $11 and kept a Buy rating.
Price Target Range — 11 Quarters
Analyst Consensus — 8 Analysts
Rating Trend — Last 9 Months
